(Lecture)282nd Monthly Meeting of Japan Pharma Licensing Assoc, “Impact of TPP on Japanese Pharmaceutical Industry”(February 17, 2016)
date : 2/17/2016
Toshio Miyata, HGPI Executive Director delivered a lecture titled, “Impact of TPP on Japanese Pharmaceutical Industry” at the 282nd Monthly Meeting of Japan Pharmaceutical Licensing Association.
Top Research & Recommendations Posts
- [Recommendations] Proposal on a Global Procurement System for Coronavirus Disease 2019 (COVID-19) Vaccines (September 7, 2020)
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [New Research Project] Initiative for the Advancement of Dementia Research and Social System Innovation through Global Public Private Partnerships (PPP)
